Related Experiment Video
Updated: Jun 20, 2026

The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques
Published on: July 3, 2014
Psoriasis: Perspectives from Irwin M. Braverman, MD
Jeffrey M Cohen1, Christopher G Bunick2
1Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut.
Abstract:
Dr Irwin M. Braverman is recognized as an expert on many skin diseases, including psoriasis, an immune-mediated disorder that presents with scaly erythematous plaques. The most common clinical subtype is plaque psoriasis, with scalp, inverse, guttate, pustular, and nail psoriasis representing additional subtypes. Psoriasis has been associated with several comorbidities, particularly psoriatic arthritis, which affects up to 30% of those with psoriasis. Psoriasis can have an enormous impact on patients, and Dr Braverman reflects that "it is hard to think of another disease that can be so destructive or impactful." Over the course of his career, Dr Braverman treated many patients with psoriasis and observed several significant therapeutic advances, including the widespread use of psoralens with UV-A phototherapy and the introduction of methotrexate. He also contributed to research on the pathophysiology of psoriasis, studying the hallmark dilated capillary loops. Dr Braverman ultimately believes that "taking care of a patient with psoriasis goes into the making of a dermatologist."
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Rocky Mountain Spotted Fever
Clinical Significance of Antibiotic Resistance
Multiple Sclerosis l: Introduction

